“Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study”, J. Trop. Pharm. Chem, vol. 5, no. 4, pp. 347–352, Dec. 2021, doi: 10.30872/j.trop.pharm.chem.v5i4.257.